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Abstract
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The effect of perfectionism on acute treatment outcomes was explored in a randomized controlled
trial of 439 clinically depressed adolescents (12–17 years of age) enrolled in the Treatment for
Adolescents with Depression Study (TADS) who received cognitive behavior therapy (CBT),
fluoxetine, a combination of CBT and FLX, or pill placebo. Measures included the Children’s
Depression Rating Scale–Revised, the Suicidal Ideation Questionnaire–Grades 7–9, and the
perfectionism subscale from the Dysfunctional Attitudes Scale (DAS). Predictor results indicate that
adolescents with higher versus lower DAS perfectionism scores at baseline, regardless of treatment,
continued to demonstrate elevated depression scores across the acute treatment period. In the case

Copyright © Taylor & Francis Group, LLC
Correspondence should be addressed to Rachel H. Jacobs, who is now at Columbia University Medical Center, Behavioral Medicine
Division, Department of Psychiatry, 1150 St. Nicholas Avenue, Suite 1-121, New York, NY 10032. rj2310@columbia.edu.
Full terms and conditions of use: http://www.informaworld.com/terms-and-conditions-of-access.pdf
This article may be used for research, teaching and private study purposes. Any substantial or systematic reproduction, re-distribution,
re-selling, loan or sub-licensing, systematic supply or distribution in any form to anyone is expressly forbidden.
Publisher's Disclaimer: The publisher does not give any warranty express or implied or make any representation that the contents will
be complete or accurate or up to date. The accuracy of any instructions, formulae and drug doses should be independently verified with
primary sources. The publisher shall not be liable for any loss, actions, claims, proceedings, demand or costs or damages whatsoever or
howsoever caused arising directly or indirectly in connection with or arising out of the use of this material.
Disclosure: Susan Silva is a consultant with Pfizer. Christopher Kratochvil receives research support from McNeil, Abbott, Shire, Eli
Lilly, and Cephalon, and is a consultant for Abbott, Eli Lilly, Pfizer, Cephalon, AstraZeneca, Organon, and Shire, and is on the Speaker’s
Bureau of Eli Lilly. Golda Ginsburg received research support from Pfizer. John March is a consultant or scientific advisor to Pfizer,
Lilly, Wyeth, GSK, Jazz, and MedAvante and holds stock in MedAvante; he receives research support from Lilly and study drug for an
NIMH-funded study from Lilly and Pfizer. The other authors have no financial relationships to disclose.

Jacobs et al.

Page 2

of suicidality, DAS perfectionism impeded improvement. Treatment outcomes were partially
mediated by the change in DAS perfectionism across the 12-week period.
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Cognitive factors have been associated with the development of depression in both adults and
adolescents and serve as a focus of cognitive behavior therapy (CBT; for a review see Clark
& Beck, 1999). In adolescents, cognitions such as dysfunctional attitudes, hopelessness, and
critical self-referent attributions have been linked to vulnerability to depression (e.g.,
Abramson, Metalsky, & Alloy, 1989). One dysfunctional attitude, perfectionism, has been
linked to a vulnerability to and the maintenance of depression. Weissman and Beck’s (1978)
Dysfunctional Attitude Scale (DAS) purports to measure self-defeating attitudes theorized to
underlie clinical depression and anxiety. The DAS, as such, assesses a unitary perfectionism
construct that could also be described as high personal standards or maladaptive evaluation
concerns. Factor analytic work of the DAS scale with adults has consistently yielded subscales
that have been labeled perfectionism (e.g., Imber et al., 1990), performance evaluation (Cane,
Olinger, Gotlib, & Kuiper, 1986), and externalized self-esteem (Oliver & Baumgart, 1985).
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In this article, we use the term DAS perfectionism when referring to the perfectionism subscale
of the DAS, for clarity and parsimony. When referring to perfectionism as a more general
construct, we use the term perfectionism. Although other measures of perfectionism exist (e.g.,
Hewitt & Flett, 1991b) and assess multidimensional components of perfectionism, this study
evaluated DAS perfectionism in line with Beck’s model (Brown & Beck, 2002). Brown and
Beck pointed out that “it thus can be argued that the DAS is, to a substantial degree, a measure
of perfectionism, if perfectionism is construed in broad terms” (p. 236). Use of the DAS
Perfectionism subscale allows for comparisons with relevant findings from two large studies,
namely, the Treatment of Depression Collaborative Research Program (TDCRP; Blatt,
Quinlan, Pilkonis, & Shea, 1995) and the Oregon Adolescent Depression Project (Lewinsohn,
Hops, Roberts, Seeley, & Andrews, 1993). Recent work has also further explicated relations
between various constructs of perfectionism and depression (see Powers, Zuroff, & Topciu,
2004).

NIH-PA Author Manuscript

Perfectionism appears to predispose to, precipitate, and prolong depression among university
students, adult community samples, and adult psychiatric patients (Chang, 2000; Hewitt &
Flett, 1991a; Rice, Ashby, & Slaney, 1998). A small number of studies have focused on
relations between perfectionism and depression among children and adolescents (e.g., Einstein,
Lovibond, & Gaston, 2000). Of interest, perfectionism and hopelessness are highly correlated
in adolescents (Donaldson, Spirito, & Farnett, 2000). Grzegorek, Slaney, Franze, and Rice
(2004) observed that perfectionism is related to self-critical depression but not dependent
depression. In this case, self-critical depression refers to an introjective focus on self-worth,
failure, worthlessness, and guilt, whereas dependent depression refers to depression associated
with loneliness, helplessness, and fear of abandonment. Cole (1991) hypothesized that children
develop self-perceptions based on feedback from others regarding their competence. In line
with Cole’s reasoning, a child’s perception of failing to meet perfectionistic expectations
affects the child’s self-perceptions, resulting in depression. Taken together, these findings
indicate that perfectionism is associated with depression and other psychiatric symptoms in
adults, whereas such relations are less clear among children and adolescents.
Higher levels of perfectionism may also potentiate forms of suicidality and hopelessness among
adult psychiatric inpatients, outpatients, and college samples (Dean, Range, & Goggin, 1996;
Hewitt, Flett, & Weber, 1994). Several studies have also examined relations between various
forms of suicidality and perfectionism in adolescent psychiatric samples. Perfectionism among
adolescents has been found, for example, to be linked with both suicide threat and intent
(Hewitt, Flett, & Turnbull-Donovan, 1992; Hewitt, Newton, Flett, & Callander, 1997). In
Boergers, Spirito, and Donaldson’s (1998) study of depressed adolescents, perfectionism
J Clin Child Adolesc Psychol. Author manuscript; available in PMC 2010 November 1.
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discriminated between adolescent suicide attempters with a high intent to die and those with
no intent to die. These findings suggest perfectionism may be associated with suicidality among
adolescents.
Another important issue is understanding perfectionism’s relationship to treatment response.
It is possible that CBT may be a more or less effective treatment than noncognitive therapies
for individuals with depression and high levels of perfectionism. CBT, which is based on
Beck’s cognitive model (e.g., Clark & Beck, 1999), attempts to rectify dysfunctional attitudes
and beliefs associated with depression. The CBT protocol used in the Treatment for
Adolescents with Depression Study (TADS) addressed cognitive factors believed to maintain
depression, including perfectionism, within (a) CBT case formulation, (b) treatment
expectations and goals, (c) cognitive distortions and realistic counter-thoughts, (d)
maintenance, and (e) relapse prevention (as detailed in the TADS CBT manual available at
https://trialweb.dcri.duke.edu/tads/tad/manuals/TADS_CBT.pdf).
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Level of perfectionism prior to treatment may predict treatment outcome. Results from the
National Institute of Mental Health TDCRP data indicate that therapeutic outcome in adults
was significantly related to pretreatment level of DAS perfectionism (Blatt et al., 1995). Higher
levels of DAS perfectionism predicted poor treatment outcome as indicated by severity of
depression, general clinical functioning, and social adjustment in all four treatment conditions
(Interpersonal Therapy, CBT, imipramine plus clinical management, and placebo control plus
clinical management). As such, individuals with high levels of perfectionism may have
unrealistic coping goals and standards that may undermine the recovery process or the
maintenance of gains (Hewitt & Flett, 1996). Alternatively, perfectionism may function to
decrease social support and increase interpersonal difficulties (e.g., Shahar, Blatt, & Zuroff,
2007; Zuroff & Blatt, 2002). In sum, evidence suggests that pretreatment perfectionism may
predict treatment outcome among adults.
Alternatively, level of perfectionism prior to treatment may moderate treatment outcome.
Moderator effects are prescriptive in that they explicate which individuals are more likely to
benefit from a particular treatment versus another (Kraemer, Wilson, Fairburn, & Agras,
2002). As Kraemer and colleagues noted, “conceptually, moderators identify on whom and
under what circumstances treatments have different effects” (p. 877). As such, a moderator
variable interacts with treatment group, whereas a predictor variable does not. It remains
unknown if pretreatment level of DAS perfectionism moderates treatment response for
depression.

NIH-PA Author Manuscript

No studies to date in the adolescent literature have examined whether level of perfectionism
during treatment for depression mediates outcome. Mediators are postrandomization factors
that may represent mechanisms of treatment response. Ingram and colleagues (2006)
highlighted the importance of exploring mediation: “The idea that cognition serves as the
central mediating process is not new, and goes back at least to Beck’s (1967) speculation on
the nature of depression” (p. 85). In light of the critical nature of mediation to cognitive models
of depression, we evaluated this process in a large sample of depressed adolescents. However,
given findings in the adult literature that medication can lead to significant cognitive change
(e.g., Simons, Garfield, & Murphy, 1984), we further hypothesized that perfectionism would
mediate treatment response within all treatment modalities. The identification of a mediator
leads naturally to hypotheses about causal processes, which can be tested in studies specifically
designed for these purposes. Randomized controlled trials are designed to test the efficacy of
treatments and offer fruitful ground for the testing of moderators and mediators. However,
moderators and mediators must be tested a priori within experimental studies to yield
conclusive results. Within the context of randomized controlled trials, mediator analyses must
be considered hypothesis-generating rather than hypothesis-testing (Kraemer et al., 2002).
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The aim of this study was to examine whether DAS perfectionism is associated with depression
and suicidality and to determine the extent to which DAS perfectionism is associated with
treatment response among adolescents with major depression. We hypothesized that (a) DAS
perfectionism would be significantly and positively associated with depression and suicidality
severity prior to treatment, (b) pretreatment DAS perfectionism would either predict (main
effect) or moderate (interaction with treatment) depression and suicidality outcomes after 12
weeks of acute treatment for depression, and (c) changes in DAS perfectionism during the
intervention period would mediate treatment response. If perfectionism is found to moderate
treatment outcome, we will have identified a pretreatment variable that could be used to decide
what treatment may be the most helpful in the case of depressogenic cognition, such as
perfectionism. If perfectionism is found to mediate treatment outcome, we would recommend
experimental tests to explore the possibility that perfectionism represents a mechanism
whereby treatment affects depression.

METHODS
Participants
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Participants were 439 clinically depressed adolescents enrolled in the TADS. Sponsored by
National Institute of Mental Health, TADS is a randomized controlled trial comparing the
effects of CBT (n = 111), fluoxetine (FLX; n = 109), their combination (COMB; n = 107), and
a pill placebo (PBO; n = 112). Randomized treatment was administered over a 12-week acute
treatment period.
Adolescents in the TADS sample were between 12 and 17 years of age (inclusive) with a current
primary Diagnostic and Statistical Manual of Mental Disorders (4th ed.; American Psychiatric
Association, 1994) diagnosis of major depressive disorder. Fifty-four percent of the
participants were girls, 74% were Caucasian, and the mean age was 14.6 (SD = 1.5) years. A
score of 45 or greater on the Children’s Depression Rating Scale–Revised (CDRS–R;
Poznanski & Mokros, 1996) was required for study entry. The CDRS–R total scores at the
pretreatment assessment ranged from 45 to 98 (M = 60, SD = 10.4), which is indicative of mild
to severe depression. A mean total score of 60 corresponds with a normed T score of 75.5
(6.43), suggesting moderate to moderately severe depression.
Procedures
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Details of consent and assent, Institutional Review Board approval, rationale, methods, design
of the study, and other demographic and clinical characteristics of the sample are detailed in
previous reports (The TADS Team, 2003; 2005). Study assessments were conducted
immediately prior to treatment (Baseline) and at two time points during the acute treatment
period (Weeks 6 and Week 12). Clinical assessments were provided by an independent
evaluator (IE) who was blind to the treatment assignment. Several self-report questionnaires
completed by youth and parents were also collected.
Measures
CDRS–R(Poznanski & Mokros, 1996)—The CDRS–R is a 17-item clinician-rated
depression severity measure that was completed by the IE. The CDRS–R total score serves as
a primary outcome measure for the study. Scores on the CDRS–R are based on interviews with
the adolescent and parent and can range from 17 to 113, with higher scores representing more
severe depression. The scale has good internal consistency (coefficient Į = .85), interrater
reliability (r = .92), test–retest reliability (r = .78), and is correlated with a range of validity
indicators including global ratings and diagnoses of depression (Pozanski & Mokros, 1996).
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Suicidal Ideation Questionnaire–Grades 7–9—(SIQ-Jr; Reynolds, 1987). The SIQ-Jr
is a 15-item adolescent self-report measure of suicidal thinking with a possible range of scores
between 0 and 90. Severity of suicidal ideation was based on the total score, with higher scores
indicating more severe suicidality. The SIQ-Jr has high internal consistency (coefficient Į = .
94) and moderate test–retest stability (r = .72; Reynolds, 1987).
Children’s Global Assessment Scale (Rey, Starling, Wever, Dossetor, & Plapp,
1995)—The Children’s Global Assessment Scale is a measure of general functioning during
the past week, which was completed by the IE.
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Perfectionism subscale of the DAS (Weissman & Beck, 1978)—The DAS is a selfreport rating scale that assesses beliefs associated with vulnerability for depression. Although
the DAS was originally developed within adult populations, it has been used widely within
adolescent samples (e.g., Ackerson, Scogin, McKendree-Smith, & Lymen, 1998; Martin,
Kazarian, & Breiter, 1995; Williams, Connolly, & Segal, 2001). Internal consistency is good
and stability is excellent over 8 weeks among adults (Marton & Kutcher, 1993) as well as youth
(Garber, Weiss, & Shanley, 1993). The scale consists of 40 statements on a 7-point Likert scale.
Using data from the TDCRP, Imber and colleagues (1990) used a principal components
analysis to examine the factor structure of the DAS. Two distinct factors emerged and were
labeled perfectionism and need for approval. Fifteen items loaded substantially on the
perfectionism factor. The items of this subscale are listed in Table 1. The item content of the
DAS used in our study is identical to the DAS used with adults and adolescents in other studies.
The perfectionism subscale was recently identified in a factor analysis of the DAS within the
TADS sample (Rogers et al., 2009). Confirmatory factor analysis revealed a two-factor model,
with scales corresponding to perfectionism and need for social approval, which provided a
satisfactory fit to the data. The goodness-of-fit was equivalent across sexes and age groups.
The perfectionism scale demonstrated an excellent degree of internal consistency (Į = .91).
Possible scores on the perfectionism factor range from 15 to 105, with higher scores
representing greater perfectionism.
Statistical Analyses
Primary outcomes were severity of depression and suicidality during the 12-week treatment
period, as measured by IE-report CDRS–R total score and the adolescent-report SIQ-Jr total
score, respectively. An intent-to-treat analysis approach was employed, and thus all 439
patients randomized to treatment were included in analyses regardless of study completion,
protocol adherence, or treatment compliance. Given that these analyses were exploratory,
nondirectional statistical tests were conducted and the level of significance was set at .05.
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Sixteen youth were missing a DAS perfectionism score and 11 were missing a SIQ-Jr total
score at baseline. For the baseline and intent-to-treat analyses, the baseline sample median
score was imputed when a baseline score was missing. The sample median was 53 for DAS
perfectionism and 16 for the SIQ-Jr total score. The mean baseline DAS perfectionism score
was 53.7 (SD = 17.6, n = 423) without imputation and 53.7 (SD = 17.3) with imputation, while
the mean baseline SIQ-Jr total score was 23.7 (SD = 21.8, n = 428) without imputation and
23.5 (SD = 21.6) with imputation. General Linear Models with a posteriori t tests were
employed to compare the treatment arms on key baseline clinical characteristics. When the
assumptions of this test were not met, a nonparametric Kruskal-Wallis test was used. Pearson
product-moment coefficients were conducted to examine the correlation between measures at
the three assessment points.
DAS perfectionism’s effect on treatment was examined using an approach recommended by
Kraemer and colleagues (Kraemer et al., 2002). As described in the introduction, a nonspecific
J Clin Child Adolesc Psychol. Author manuscript; available in PMC 2010 November 1.
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predictor is a pretreatment variable that has a significant effect on outcome regardless of
treatment condition (i.e., main effect only—as evidenced by a perfectionism or perfectionism
× time effect). A moderator, on the other hand, is considered a special type of predictor whereby
(a) treatment effectiveness is significantly influenced by level of the pretreatment factor, and
(b) a significant interaction between the pretreatment factor and treatment (with or without a
main effect of the pretreatment factor) is demonstrated (i.e., perfectionism × treatment or
perfectionism × treatment × time). A mediator is a postrandomization factor that may represent
a mechanism or help explain treatment response. Using Kraemer et al.’s (2002) criteria, a
mediator is a postrandomization variable that is correlated with treatment and demonstrates a
significant main and / or interaction with treatment outcome.
The core random regression model (RRM) included both fixed (treatment, natural log of time,
treatment × time, site) and random (patient, patient × time) effects. As previously reported
(The TADS Team, 2004), the primary efficacy findings for the 12-week treatment period
indicated that treatment was related to the CDRS–R and SIQ-Jr outcomes. Our first step in the
current analysis was to replicate the published results using the core RRM without DAS
perfectionism terms in the model. Then, baseline DAS perfectionism and its interaction terms
(DAS perfectionism × time, DAS perfectionism × treatment, and DAS perfectionism ×
treatment × time) were added to the core model to test whether DAS perfectionism was a
predictor versus a moderator of treatment effects.
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DAS perfectionism change scores across the acute treatment period (baseline minus end of
treatment difference scores) were used to determine whether a decrease in DAS perfectionism
during the treatment period mediated outcome. DAS perfectionism change scores were
available for 368 of the 439 (83.8%) enrolled patients (COMB = 83.2%, FLX = 89.0%, CBT
= 78.4%, PBO = 84.0%) because of study exit or missing Week 12 assessments. The four
treatment arms did not differ significantly, however, in the rate of missing change score data,
Ȥ2(N = 368, 3) = 4.7, p = .196. Change scores were employed rather than time-dependent DAS
perfectionism scores to control for potential moderating effects of pretreatment scores (H. C.
Kraemer, personal communication, October 5, 2006). As derived, a more positive change score
represents a greater decrease in DAS perfectionism over the treatment period. Because of the
large variability in the change scores, a Kruskal-Wallis test was conducted to determine
whether treatment was related to change in DAS perfectionism.
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Next, an RRM was conducted to (a) examine treatment differences in DAS perfectionism over
time, and (b) derive predicted scores for each patient at baseline and Week 12, as well as change
scores, based on the individual trajectories generated by the RRM. The derived predicted
perfectionism scores are estimated scores adjusted for the fixed (treatment, natural log of time,
treatment × time, site) and random (patient, patient × time) effects in the model. Predicted
scores were generated for the purposes of imputation for the 71 youth missing a Week 12
assessment. The mean for the DAS perfectionism change score without imputation was 9.2
(SD = 17.2, n = 368) and with imputation was 9.0 (SD = 15.9, n = 439). The range was í46.0
to 83.0. If correlated with treatment, then the final step for assessing mediator status was to
conduct the RRM with DAS perfectionism change and its interaction terms in the model. Paired
contrasts were conducted only if a significant treatment or treatment × time effect was observed.

RESULTS
Baseline Analyses
Patients in the four randomized treatment conditions did not differ significantly at baseline
with regard to CDRS–R depression severity, SIQ-Jr suicidality scores, DAS perfectionism,
global functioning, age at time of consent, duration of the current depressive episode, or total
number of concurrent psychiatric disorders (all tests, p > .05). Although differences in the SIQJ Clin Child Adolesc Psychol. Author manuscript; available in PMC 2010 November 1.
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Jr total scores were not detected between the four treatment arms (Kruskal-Wallis, p = .572),
the proportion of patients with a SIQ-Jr total score of 31 or greater, which is indicative of
clinically significant suicidal risk, was significantly higher in the COMB (39.3%) arm relative
to FLX (25.7%, p = .036), CBT (24.3%, p = .025), and PBO (25.0%, p = .033).
Correlational Analyses
At baseline, DAS perfectionism scores ranged from 15 to 99 and were significantly correlated
with CDRS–R (r = .19, p < .001) and SIQ-Jr (r = .32, p < .001) total scores, with greater DAS
perfectionism associated with more severe depression and suicidality. In addition, baseline
depression and suicidality were moderately related (r = .33, p <.001). Baseline DAS
perfectionism was also correlated with Week 12 DAS perfectionism scores (r = .57, p < .001,
n = 368) and change in DAS perfectionism (r = .35, p < .001, n = 368), in that higher baseline
depression scores were associated with greater reductions in DAS perfectionism score across
the 12 weeks. Correlation coefficients were conducted to examine multicollinearity between
DAS perfectionism and outcomes at the three assessment points. The results indicated modest
cross-modal associations. For depression, the coefficient was 0.19 at baseline, 0.35 at Week
6, and 0.36 at Week 12, whereas the correlation with suicidality was 0.32 at baseline, 0.26 at
Week 6, and 0.41 at Week 12 (all p < .05).
Primary Efficacy Analysis

NIH-PA Author Manuscript

Using a RRM with site as a fixed effect we replicated our previously reported findings with
the CDRS–R and SIQ-Jr outcomes (The TADS Team, 2004). Across treatments, the percentage
of participants with a score greater than or equal to 31 (representing significantly greater
suicidal risk) ranged from 25 to 40% at baseline. At Week 12 the percentage ranged from 6 to
19%. Table 2 presents the means and standard deviations (SD) for the depression, suicidality,
and DAS perfectionism measures at baseline, Week 6, and Week 12.
Predictor and Moderator Analyses
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For the depression outcome, significant time, F(1, 408) = 94.7, p < .001, and DAS
perfectionism, F(1, 425) = 10.1, p < .002, effects were demonstrated. However, the DAS
perfectionism × treatment, F(3, 413) = 1.5, p = .215, and DAS perfectionism × treatment ×
time, F(3, 405) = 0.7, p = .579, interaction terms were not statistically significant. In addition,
the main effects of DAS perfectionism, F(1, 410) = 43.2, p <.001, and DAS perfectionism ×
time, F(1, 416) = 7.0, p <.009, were significant for the suicidality outcome, whereas the DAS
perfectionism interactions with treatment were not. A main effect (perfectionism or
perfectionism × time) in absence of an interaction with treatment (perfectionism × treatment
or perfectionism × treatment × time) indicates that DAS perfectionism was a predictor of
outcome but not a moderator of outcome. The predictor results indicate that adolescents with
higher versus lower DAS perfectionism scores at baseline, regardless of treatment, continued
to demonstrate elevated depression scores across the acute treatment period. In the case of
suicidality, DAS perfectionism impeded improvement. Adolescents with DAS perfectionism
scores at or above the 90th percentile (score  78) had higher CDRS–R and SIQ-Jr scores at
baseline and Week 12.
Mediator Analyses
The primary analysis described earlier (and The TADS Team, 2004) indicated a significant
relationship between treatment and treatment outcomes, as demonstrated by the significant
treatment × time interaction. The RRM with DAS perfectionism as the outcome demonstrated
significant time, F(1, 396) = 110.2, p < .001, and treatment × time interaction, F(3, 396) = 5.4,
p < .002, effects. Participants in COMB treatment demonstrated a greater rate of improvement
when compared to participants in the other three conditions (all p < .026), whereas participants

J Clin Child Adolesc Psychol. Author manuscript; available in PMC 2010 November 1.
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in FLX, CBT, and PBO did not differ from one another. At the end of acute treatment,
participants in COMB treatment had lower DAS perfectionism scores relative to those in CBT
and PBO (p < .006). However, participants in COMB treatment did not differ from those in
FLX (p = .065). Those in the FLX, CBT, and PBO groups did not differ significantly in terms
of DAS perfectionism at Week 12. Figure 1 details the relation between treatment group and
level of DAS perfectionism.
Next, a Kruskal-Wallis test was used to determine if DAS perfectionism change scores were
correlated with treatment. The effect of treatment on change scores was significant, Ȥ2(n = 439,
3) = 22.5, p < .001, with participants in COMB treatment presenting with a greater decrease
in DAS perfectionism relative to FLX (p < .001), CBT (p < .001), and PBO (p = .014) across
the 12 weeks. The ordering of effects was COMB > PBO, PBO, FLX, and CBT. Although
participants in FLX did not significantly differ from those in CBT (p = .510) or PBO (p = .
202), participants in CBT did not experience as great a reduction in DAS perfectionism scores
as those in PBO (p = .029). These results indicate that postrandomization change in DAS
perfectionism was associated with treatment.
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Next, we conducted the core RRM with DAS perfectionism change and its interactions included
to determine if the main effect of DAS perfectionism and / or its interaction with treatment
were significant. Significant time, F(1, 401) = 687.4, p < .001; DAS perfectionism × time, F
(1, 385) = 23.4, p < .001; and treatment × time, F(3, 402) = 3.6, p = .014, effects were
demonstrated for the depression outcome. Participants in COMB treatment experienced a
significantly greater rate of improvement in depression when compared to those in CBT (p = .
007) and PBO (p = .024). With DAS perfectionism change terms in the model, the significant
treatment × time effect was reduced from F(3, 411) = 9.1, p < .001, to F(3, 402) = 3.6, p = .
014. In addition, the slope difference between the COMB and FLX groups reported in the
primary analysis was no longer observed (p = .067). Participants in FLX evidenced
significantly greater depression change relative to those in CBT (p = .021), whereas participants
in FLX and CBT did not differ from those in PBO. Week 12 comparisons were similar to the
primary findings without DAS perfectionism change in the model (COMB = FLX > CBT =
PBO).
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With regard to suicidality, significant time, F(1, 411) = 59.2, p < .001, and DAS perfectionism
× time, F(1, 389) = 20.7, p < .001, effects were observed. The treatment × time, F(3, 402) =
3.6, p = .014, effect reported in the primary analysis was no longer statistically significant, F
(3, 410) = 1.8, p = .141. The COMB treatment participants demonstrated a greater rate of
improvement in suicidality when compared to youth receiving FLX (p = .023). No other
significant differences were detected between the four arms in terms of slope or Week 12
outcomes. In the case of suicidality, change in DAS perfectionism significantly reduced the
treatment × time interaction observed in the primary analysis.
Taken together, results indicate that change in DAS perfectionism during the acute treatment
period was a partial mediator of the depression and suicidality outcomes, as revealed by the
significant DAS perfectionism × time main effect. The main effects of DAS perfectionism
change eliminated the treatment × time interaction for suicidality while diminishing this
interaction in the case of depression. The effects of treatment across time after controlling for
postrandomization perfectionism are presented in Figure 2 and Figure 3. Effect sizes, using
Cohen’s d (Cohen, 1988), for the depression score treatment comparisons are included in Table
3. The inclusion of DAS perfectionism change in the RRM resulted in reduced effect sizes for
treatment comparisons.
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The present study sought to examine relations amongst severity of DAS perfectionism,
depression, and suicidality in a sample of clinically depressed adolescents. Our first hypothesis
was that DAS perfectionism would be significantly and positively associated with depression
and suicidality severity. This hypothesis was supported, as higher DAS perfectionism scores
were correlated with more severe depression and suicidality at the baseline, Week 6, and Week
12 assessments.
Our second hypothesis was that pretreatment DAS perfectionism would either predict (main
effect) or moderate (interaction with treatment) depression and suicidality outcomes after 12
weeks of acute treatment for depression. DAS perfectionism had predictive value given that
depressed adolescents with higher levels of DAS perfectionism scores continued to
demonstrate consistently elevated depression scores over the acute treatment period. In regard
to the suicidality outcome, adolescents with higher levels of DAS perfectionism scores at
baseline experienced less improvement over the acute treatment period, regardless of treatment
type. All treatments resulted in decreases in DAS perfectionism, with the combination of CBT
and medication resulting in the greatest decrease.
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Care must be taken, however, in drawing broad conclusions from these results. Whereas
perfectionism has been shown to be a relatively stable trait among adults (Cox & Enns,
2003), this may not be the case among adolescents. A recent study found that dysfunctional
attitudes were not stable in early to middle adolescence but exhibited relative stability during
middle to late adolescence (Hankin, 2005). As participants in the TADS study ranged from 12
to 17 years of age, it is possible that the stability of perfectionism may have varied with age.
Further longitudinal studies, of both normal and clinical samples, may help establish the fluidity
or stability of perfectionism over time, independent of changes associated with the treatment
for depression.
Although highly perfectionistic adolescents did not benefit as much from treatment as their
less perfectionistic counterparts, it is noteworthy that brief treatment, both pharmacological
and psychological, was still effective in this population. Previous findings suggested that adults
with strong perfectionistic tendencies may respond better to long-term, intensive,
psychodynamic treatments than to short-term treatments (Blatt & Ford, 1994). Moreover, Blatt
et al. (1995) proposed that in targeting perfectionism through treatment, therapists are
attempting to change personality structure, a goal that necessitates a longer time frame than
short-term therapy allows. Our finding that all treatment groups experienced a significant
reduction in DAS perfectionism suggests that certain dysfunctional attitudes may not be as
resistant to change as previously thought, at least among some youth.
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Our third hypothesis regarding DAS perfectionismand treatment response was also supported
as perfectionism mediated the effect of treatment on depression and suicidality, reducing and
eliminating the treatment effect in each case respectively. Including DAS perfectionism in our
statistical model resulted in modest changes in effect sizes for treatment comparisons. The
moderate correlations between DAS perfectionism and treatment outcomes, coupled with the
continued statistical significance of DAS perfectionism after controlling for the effects of
treatment and time, suggest that mediation effects cannot be explained as a function of
multicollinearity.
Our results suggest that DAS perfectionism is implicated as a mediator and possible mechanism
in the treatment of depression among adolescents. As Kraemer and colleagues (2002) pointed
out, “All mechanisms [of treatment] are mediators but not all mediators are mechanisms” (p.
878). The identification of mediators represents the first step in examining possible
mechanisms of change. To be sure, demonstrating causality is more difficult than establishing
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mediator status. Additional research is necessary to demonstrate the mechanism of
perfectionism. Our current analyses, therefore, must be considered exploratory. Recent
reanalysis of the TDCRP data indicated dual change processes, wherein DAS perfectionism
predicted subsequent change in depression and the strength of the therapeutic alliance predicted
change in perfectionism (Hawley, Ho, Zuroff, & Blatt, 2006). Advancing our understanding
of change processes, including that of mediation, will allow for the refinement of existing
treatments as well as the development of new treatments.
Our finding that medication changed DAS perfectionism is congruent with research among
adults suggesting that medication can change cognition (e.g., Simons et al., 1984). Cognitive
models of depression posit that CBT works by changing cognition (e.g., Beck, 1967).
Demonstrating this, however, has proven challenging (Clark & Beck, 1999). In a provocative
recent study, latent depressive schemas, as measured by a scale of cognitive reactivity, were
found to be associated with sensitivity to a reduction of 5-HT (Booij & Van der Does, 2007).
It is possible, as such, that the cognitive and neurobiological substrates of depression are linked.
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Confidence in our interpretation of the results obtained is constrained by several factors. First,
other measures that tap multiple dimensions of perfectionism exist and associations between
these measures of perfectionism and measures of mood may vary. Thus, although this study
contributes to existing empirical work on perfectionistic dysfunctional attitudes, how this study
speaks to the larger empirical and theoretical literature on the construct of perfectionism
remains to be demonstrated. Indeed, researchers have distinguished between social prescribed
perfectionism and other-oriented perfectionism (Hewitt & Flett, 1991b). Brown and Beck
(2002) noted that the DAS perfectionism factor parallels Hewitt and Flett’s (1991b) construct
of socially prescribed perfectionism, as both relate to the internalization of socially dictated
norms. Thus, our findings regarding DAS perfectionism reflect the self-focused, depressogenic
cognitive set described in Beck’s (1967) model. Replication of our results with other measures
of perfectionism is warranted.
Site was retained in the model and treated as a fixed effect in our analysis because treatments
were nested within each clinical site. To be consistent with the statistical analysis approach
applied in the TADS primary analysis (The TADS Team, 2004), we included site as a covariate
in the current analysis. In the primary and current secondary analysis, the site interaction terms
were omitted from the final regression models due to a lack of statistical significance (p > .
05).
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In addition, methods for demonstrating mediation continue to develop. Such methods, in
combination with research utilizing more temporally sensitive designs, may further explicate
transactional relations between perfectionism and treatment outcomes. Our findings suggest
that DAS perfectionism changes in tandem with depressive symptoms. As DAS perfectionism
decreases, depression and level of suicidality appear to similarly decline. Microanalytic studies
designed to assess change in cognition over the course of treatment for depression would
advance knowledge in this domain. Similarly, although we could not assess the degree to which
DAS perfectionism was addressed during CBT sessions, dose effects could be explored in such
microanalytic work. Moreover, some have suggested that temporal precedence is essential in
defining a mediator (e.g., Kazdin & Nock, 2003; Weersing & Weisz, 2002). We note that
although establishing that a variable is a mediator indicates the existence of relations between
the treatment and the mediator, these relations may or may not be causal. The definition of
mediators proposed by Kraemer and her colleagues (2002) does not assume that the causal
pathways are known nor is any necessary causal role assumed once identified. Often the
identification of a mediator leads to hypotheses about the possible causal role to be tested in
future studies specifically design for those purposes. Thus, temporal precedence is a theoretical
rather than an analytic criterion for mediation. Although we recognize the importance of this
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theoretical criterion, we present our results in the hopes of generating further studies that can
test these change processes in a more sensitive manner. Last, the inclusion of DAS
perfectionism in our statistical model led to modest changes in effect sizes. However, given
that change is likely multiply determined, modest mediator effects remain clinically relevant.
Within the context of these limitations, our findings offer support for the notion that DAS
perfectionism is related to both adolescent depression and suicidality. Clinicians may find it
helpful, as a consequence, to assess levels of dysfunctional attitudes, such as perfectionism,
among depressed youth and to target such cognition in therapy. Although DAS perfectionism
did not moderate treatment outcome, given the robust outcomes evidenced in the COMB
treatment with respect to depression, suicidality, and DAS perfectionism—combination
treatment may be the safest recommendation in light of current evidence.
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FIGURE 1.

Change in Dysfunctional Attitudes Scale Perfectionism subscale scores (DAS) over 12 weeks
of treatment. Note: Base = baseline; COMB = CBT and fluoxetine; FLX = fluoxetine; CBT =
cognitive behavior therapy; PBO = pill placebo; Wk = week.
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FIGURE 2.

Children’s Depression Rating Scale–Revised (CDRS–R) total scores adjusted for
Dysfunctional Attitudes Scale perfectionism change scores. Note: Base = baseline; COMB =
CBT and fluoxetine; FLX = fluoxetine; CBT = cognitive behavior therapy; PBO = pill placebo;
Wk = week.

NIH-PA Author Manuscript
J Clin Child Adolesc Psychol. Author manuscript; available in PMC 2010 November 1.

Jacobs et al.

Page 16

NIH-PA Author Manuscript
NIH-PA Author Manuscript

FIGURE 3.

The Suicidal Ideation Questionnaire Grades 7–9 total score (SIQ-Jr) adjusted for Dysfunctional
Attitudes Scale perfectionism change scores. Note: Base = baseline; COMB = CBT and
fluoxetine; FLX = fluoxetine; CBT = cognitive behavior therapy; PBO = pill placebo; Wk =
week.
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TABLE 1

Dysfunctional Attitude Scale Perfectionism Items
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Item #

Item

1

It is difficult to be happy unless one is good looking, intelligent, rich and creative.

3

People will probably think less of me if I make a mistake.

4

If I do not do well all the time, people will not respect me.

8

If a person asks for help, it is a sign of weakness.

9

If I do not do as well as other people, it means I am an inferior human being.
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10

If I fail at my work, then I am a failure as a person.

11

If you cannot do something well, there is little point in doing it at all.

13

If someone disagrees with me, it probably indicates he does not like me.

14

If I fail partly, it is as bad as being a complete failure.

15

If other people know what you are really like, they will think less of you.

20

If I don’t set the highest standards for myself, I am likely to end up a second-rate person.

21

If I am to be a worthwhile person, I must be truly outstanding in at least one major respect.

22

People who have good ideas are more worthy than those who do not.

23

I should be upset if I make a mistake.

26

If I ask a question, it makes me look inferior.
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378

Week 12

362
370

Week 6

Week 12

439
307
368
368
439

Baseline

Week 6

Week 12

Change score-unadjusted

Change score-adjusted

DAS subscale score

439

Baseline

SIQ-Jr total score

389

Week 6

8.8 + 16.2

9.2 + 17.2

45.2 ± 19.6

48.2 ± 17.5

53.7 ± 17.3

13.4 ± 16.5

15.2 ± 17.6

23.5 ± 21.6

38.2 ± 13.4

42.1 ± 12.3

60.1 ± 10.4

M ± SD

107

89

89

71

107

90

86

107

95

98

107

N

14.4 + 16.0

14.8 + 17.5

40.0 ± 20.8

44.2 ± 18.7

54.1 ± 17.4

12.5 ± 16.5

14.2 ± 18.4

27.2 ± 24.5

33.4 ± 11.9

38.5 ± 12.7

60.8 ± 11.6

M ± SD

COMB
N

109

97

97

84

109

97

95

109

97

99

FLX

6.6 + 15.9

6.4 + 16.8

46.1 ± 19.4

46.6 ± 17.3

52.2 ± 16.3

14.8 ± 17.3

16.1 ± 18.5

21.8 ± 19.1

36.8 ± 12.7

39.4 ± 11.5

59.0 ± 10.2

M ± SD

111

87

87

76

111

91

89

111

90

97

111

N

CBT

5.5 + 12.8

5.7 + 14.4

47.5 ± 16.9

51.3 ± 16.2

52.3 ± 17.3

11.9 ± 14.9

12.8 ± 14.9

21.8 ± 21.0

41.4 ± 14.2

45.3 ± 11.8

59.6 ± 9.2

M ± SD

112

95

95

76

112

92

92

112

96

95

112

N

PBO

9.6 + 17.2

10.1 + 18.6

47.1 ± 20.3

50.5 ± 17.3

56.0 ± 18.0

14.4 ± 17.3

17.6 ± 18.3

23.4 ± 21.3

41.4 ± 13.4

45.4 ± 11.6

61.1 ± 10.5

M ± SD

Note. COMB = CBT and fluoxetine; FLX = fluoxetine; CBT = cognitive behavior therapy; PBO = pill placebo; CDRS–R = Children’s Depression Rating Scale–Revised total score; SIQ-Jr = The Suicidal
Ideation Questionnaire Grades 7–9 total score; DAS = Dysfunctional Attitudes Scale Perfectionism subscale score.

Perfectionism

Suicidality

439

CDRS–R total score

Depression

N

Baseline

Assessment

Domain

Total

109
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Depression, Suicidality, and Perfectionism: Means and Standard Deviations
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TABLE 3

Effect Sizes (ES) for CDRS–R Depression Score Treatment Comparisons
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ES Without
Perfectionism Change

ES With
Perfectionism Change

COMB vs. PBO

0.98

0.96

FLX vs. PBO

0.68

0.64

CBT vs. PBO

í0.03

í0.02

COMB vs. FLX

0.31

0.33

COMB vs. CBT

0.95

0.92

FLX vs. CBT

0.66

0.62

Comparison
Active vs. PBO

Active treatments

Note. PBO = placebo; Base = baseline; COMB = CBT and fluoxetine; FLX = fluoxetine; CBT = cognitive behavior therapy.
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